K-group, Beta, Inc., A Wholly Owned Subsidiary Of Zentalis Pharmaceuticals, Inc

This study is testing an oral medication called azenosertib for women with a specific type of advanced ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based chemotherapy. The trial focuses on participants whose tumors test positive for a prot…